Stay updated on HER2/EGFR Mutant Tumors Clinical Trial
Sign up to get notified when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.

Latest updates to the HER2/EGFR Mutant Tumors Clinical Trial page
- CheckyesterdayChange DetectedRevision notes updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry v3.4.3 was added to the history, and the previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.4.2 was added to the page history, replacing the previous v3.4.1; this is a minor maintenance update that does not affect study data or core content (To avoid being alerted by small changes, set an alert condition by clicking below).SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Revision: v3.4.1. Removed the funding-lapse notice and the prior Revision: v3.4.0 reference.SummaryDifference0.4%

- Check52 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH facilities' operating status was added to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check59 days agoChange DetectedThe history page now includes a glossary toggle and color-coded highlights for additions and deletions. Labels have been updated to reflect No FEAR Act Data and Revision: v3.4.0.SummaryDifference0.5%

Stay in the know with updates to HER2/EGFR Mutant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.